ConductScience.org, home

Paper22014161

Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts.

Axelsen LN and 9 others. Br J Pharmacol, 2012. Cited by 26 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts. Papers, record 22014161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22014161

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts.
PubMed
Journal
Br J Pharmacol
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
0.74
iCite
Revised in PubMed
2021-10-20
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Axelsen LNL N
2Keung WW
3Pedersen HDH D
4Meier EE
5Riber DD
6Kjølbye ALA L
7Petersen JSJ S
8Proctor SDS D
9Holstein-Rathlou NHN-H
10Lopaschuk GDG D

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cardiotonic AgentsMajor topic
GlucagonMajor topic
Glucagon-Like Peptide 1Major topic
HeartMajor topic
Insulin ResistanceMajor topic
PeptidesMajor topic
Adenosine Triphosphate
Animals
Blood Pressure
Glucose
Glycolysis
HEK293 Cells
Heart Rate
Humans
Male
Oxidation-Reduction
Palmitates
Rats

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117174230Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure.J Card Fail2006https://conductscience.org/library/papers/17174230PubMed
212464581Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats.Am J Physiol Endocrinol Metab2003https://conductscience.org/library/papers/12464581PubMed
319681866Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?Br J Pharmacol2009https://conductscience.org/library/papers/19681866PubMed
410234590A review of potential cardiovascular uses of intravenous glucagon administration.J Clin Pharmacol1999https://conductscience.org/library/papers/10234590PubMed
51757353Myocardial function and energy substrate metabolism in the insulin-resistant JCR:LA corpulent rat.J Appl Physiol (1985)1991https://conductscience.org/library/papers/1757353PubMed
616489128Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts.J Pharmacol Exp Ther2006https://conductscience.org/library/papers/16489128PubMed
716265509Therapy insight: heart disease and the insulin-resistant patient.Nat Clin Pract Cardiovasc Med2005https://conductscience.org/library/papers/16265509PubMed
811780125Superoxide activates mitochondrial uncoupling proteins.Nature2002https://conductscience.org/library/papers/11780125PubMed
917928588The physiology of glucagon-like peptide 1.Physiol Rev2007https://conductscience.org/library/papers/17928588PubMed
109278241Measurements of fatty acid and carbohydrate metabolism in the isolated working rat heart.Mol Cell Biochem1997https://conductscience.org/library/papers/9278241PubMed
1118427132Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.Circulation2008https://conductscience.org/library/papers/18427132PubMed
1217696565Pharmacologic therapy of chronic heart failure.Am J Cardiovasc Drugs2007https://conductscience.org/library/papers/17696565PubMed
134303624Activation of adenyl cyclase by glucagon in cat and human heart.Circ Res1969https://conductscience.org/library/papers/4303624PubMed
1419540343The cardioprotective and inotropic components of the postconditioning effects of GLP-1 and GLP-1(9-36)a in an isolated rat heart.Pharmacol Res2009https://conductscience.org/library/papers/19540343PubMed
1516024574Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy.Am J Physiol Heart Circ Physiol2005https://conductscience.org/library/papers/16024574PubMed
1621060752Exendin-4 protects oxidative stress-induced β-cell apoptosis through reduced JNK and GSK3β activity.J Korean Med Sci2010https://conductscience.org/library/papers/21060752PubMed
1720448207Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.Arterioscler Thromb Vasc Biol2010https://conductscience.org/library/papers/20448207PubMed
187242704A pharmacological method to estimate the pKi of competitive inhibitors of agonist uptake processes in isolated tissues.Naunyn Schmiedebergs Arch Pharmacol1981https://conductscience.org/library/papers/7242704PubMed
194391663Effect of glucagon on cyclic 3',5'-AMP, phosphorylase activity and contractility of heart muscle of the rat.Circ Res1970https://conductscience.org/library/papers/4391663PubMed
2015313949Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.Circulation2004https://conductscience.org/library/papers/15313949PubMed

See all 31 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
40458047Obesity and heart failure: exploring the cardiometabolic axis.Cardiovasc Res2025https://conductscience.org/library/papers/40458047PubMed
38832935Glucagon-like peptide-1 increases heart rate by a direct action on the sinus node.Cardiovasc Res2024https://conductscience.org/library/papers/38832935PubMed
32967969Agonist-activated glucagon receptors are deubiquitinated at early endosomes by two distinct deubiquitinases to facilitate Rab4a-dependent recycling.J Biol Chem2020https://conductscience.org/library/papers/32967969PubMed
29576852
ZP2495 Protects against Myocardial Ischemia/Reperfusion Injury in Diabetic Mice through Improvement of Cardiac Metabolism and Mitochondrial Function: The Possible Involvement of AMPK-FoxO3a Signal Pathway.
Oxid Med Cell Longev2018https://conductscience.org/library/papers/29576852PubMed
25685700Cardiomyocyte glucagon receptor signaling modulates outcomes in mice with experimental myocardial infarction.Mol Metab2015https://conductscience.org/library/papers/25685700PubMed
25685695Glucagon signaling in the heart: Activation or inhibition?Mol Metab2015https://conductscience.org/library/papers/25685695PubMed
25157099Cardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure.J Biol Chem2014https://conductscience.org/library/papers/25157099PubMed
24910203Impact of glucagon-like peptide-1 on myocardial glucose metabolism revisited.Rev Endocr Metab Disord2014https://conductscience.org/library/papers/24910203PubMed
24309637Drugs with dual-hormone action gain attention in diabetes field.Nat Med2013https://conductscience.org/library/papers/24309637PubMed
24147975Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy.Br J Pharmacol2014https://conductscience.org/library/papers/24147975PubMed
23478327Emerging combinatorial hormone therapies for the treatment of obesity and T2DM.Nat Rev Endocrinol2013https://conductscience.org/library/papers/23478327PubMed
23019069Unraveling oxyntomodulin, GLP1's enigmatic brother.J Endocrinol2012https://conductscience.org/library/papers/23019069PubMed
23011203Procedure for calculation of potency and efficacy for ligands acting on Gs- and Gi-coupled receptors.Neurochem Res2012https://conductscience.org/library/papers/23011203PubMed
22960075The glucagon-like peptide-1 receptor agonist Exendin 4 has a protective role in ischemic injury of lean and steatotic liver by inhibiting cell death and stimulating lipolysis.Am J Pathol2012https://conductscience.org/library/papers/22960075PubMed
22489621Secretin family (Class B) G protein-coupled receptors - from molecular to clinical perspectives.Br J Pharmacol2012https://conductscience.org/library/papers/22489621PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22014161

GET https://conductscience.org/api/papers/v1/22014161/references?page=2